WELL Health’s $70 Million Bought Deal Offering of Convertible Debentures

Wildeboer Dellelce LLP acted for the underwriters in connection with the offering. WELL Health Technologies Corp. (TSX: WELL) completed an oversubscribed bought deal prospectus supplement offering…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here